|
Would
you buy a Hyundai based on Volvo safety rating?
No!
So, when someone quotes you VAX-D research and then shows you
a different table, DO NOT EXPECT THE SAME RESULTS
Due
to the unprecedented success of VAX-D with low back pain there
are many Copy-Cat machines quoting VAX-D research. Beware of
other traditional traction tables that advertise as decompression.
VAX-D is patented technology that is cleared by the FDA. It
has published results and proven decompression of the disc (study
#1 below.)
Ask
any doctor to see the research! Every week, I see patients who
have tried other so-called decompression tables.
Be careful what they are selling you.
VAX-D
Medical Studies & Publications.
1.
Journal of Neurosurgery (Vol. 81: 350-353, 1994) Effects
of Vertebral Axial Decompression on Intradiscal Pressure University
of Texas, San Antonio, TX
RESULTS:
proof that VAX-D creates a negative intradiscal
pressure force up to -160mmHg.
2.
Journal of Orthopedic & Sports Physical Therapy (Vol.
35, No.1, January 2005) Short and Long-term Outcomes Following
Treatment with the VAX-D Protocol for Patients with Chronic,
Activity-limiting Low Back Pain University of South Carolina,
Columbia, SC; Virginia Commonwealth University, Richmond, VA
OUTCOME:
Significant improvements with VAX-D in
a sample of patients with unfavorable prognosis due to chronic
low back pain.
3.
Journal of Neurological Research (Vol. 26, April 2004) Efficacy
of Vertebral Axial Decompression on Chronic Low Back Pain Dr.
Gustav Ramos, Valley Neurological Center, McAllen, Texas
RESULTS:
This 744 patient study showed 76% achieved
remission of pain. Except in emergent conditions, VAX-D should
be used on all patients before surgery is undertaken.
4.
Canadian Journal of Clinical Medicine (Vol. 5, No.1, January
1998) The Effects of VAX-D on Sensory Nerve Dysfunction in Patients
with Low Back Pain and Radiculopathy by Tilaro & Miscovich
RESULTS:
The average pain reduction was 77%.
5.
Journal of Neurological Research (Vol. 20, No.3, April 1998)
Vertebral Axial Decompression Therapy for Pain Associated with
Herniated or Degenerative Discs or Facet Syndrome: Outcome Study
of 778 Cases Gose E., Ph.D, Naguszewski w., MD, Naguszewski
R, MD
RESULTS:
The authors consider VAX-D to be a primary
modality for low back pain for lumbar herniations at single
and multiple levels, degenerative discs and facet arthropathy,
and decreased spinal mobility.
6.
Anesthesiology News, (Vol. 29, No.3, March 2003) VAX-D Reduces
Chronic Discogenic Low Back Pain- 4 year Study Robert H Odell,
M.D, Ph.D, Daniel A Boudreau, D.O.
RESULTS:
Four year follow-up after VAX-D treatment shows a sustained
86% reduction in pain and that 91% of patients resumed their
normal activities.
7.
Neurological Research Journal (Vol. 23, p. 706-714, October
2001) Dermatosomal Somatosensory Evoked Potential Demonstration
of Nerve Root Decompression after VAX-D Therapy William K. Naguszewski,
M.D, Robert K. Naguszewski, M.D, Coosa Medical Group, Earl E.
Gose, Ph.D; Dept. of Neurology Dept. of Bioengineering, University
of Illinois
RESULTS:
Pain reduction in the study group was 77% with successful decompression
of the nerve roots at multiple levels.
8.Neurological
Research Journal (Vol. 23, p. 780-784, October 2001) A Prospective
Randomized Controlled Study of VAX-D and Tens for the Treatment
of Chronic Low Back Pain Department of Orthopedics, Sydney University,
Eugene Sherry, MD., F.RAC.S., Peter Kitchener, MB.B.S. FRANZCR,
Russel Smart, MB, ChB.
RESULTS:
Significant reduction in pain and improvement
in functional outcome was obtained in patients with chronic
low back pain treated with VAX-D.
9.
Canadian Journal of Clinical Medicine (Vol. 6, No.1, January
1999) An Overview of Vertebral Axial Decompression by Frank
Tilaro, MD.
RESULTS:
VAX-D is significantly capable of influencing
sensory nerve dysfunction associated with a compressive radiculopathy.
Complete remission was achieved by 73% of the study group.
10.
Journal of Orthopedic & Sports Physical Therapy (Vol.
35, No.1, January 2005) Short and Long-term Outcomes Following
Treatment with the Vax-D Protocol for Patients with Chronic,
Activity-limiting Low Back Pain University of South Carolina,
Columbia, SC; Lebanon Valley College, Lancaster, PA; Virginia
Commonwealth University, Richmond, VA
RESULTS:
Significant improvements in a sample of
patients with unfavorable prognosis due to chronic low back
pain.
NON-SURGICAL
SPINE AND DISC CENTER USES ONLY F.D.A. CLEARED VAX-D
TECHNOLOGY. TRUST NO OTHER COPYCAT MACHINES WITH YOUR HEALTH.
|